Impacting the Financial Sustainability of Healthcare Systems While Improving Access to Medicines
Understanding the complexities of biosimilars and ensure the best prescriptions and the most efficacious treatment possible to patients.
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Influencing national, EU, and global health policy and informing medical oncologists
ESMO’s Public Policy Division supports ESMO members by engaging with EU, global, and national authorities on issues related to the practice and profession of medical oncology. For more information about our activities, please download our Public Policy Brochure.
Read more about the virtual event and ESMO Call to Action
A framework to rank genomic alterations as targets for cancer precision medicine.
Understanding the complexities of biosimilars and ensure the best prescriptions and the most efficacious treatment possible to patients.
Promoting clear and unbiased communication about the benefits of cancer treatments
Join us for ESMO webinars on the major policy topics at the EU and global level to remain informed about how they affect your life, your profession and your patients.
Celebrate ESMO’s 2011 achievement of the recognition of the profession of medical oncology in Europe. Locate national contact points for working across borders, and find answers to FAQs.
Learn about ESMO’s recommendations and call to action to prevent and manage medicines shortages that negatively impact the health of citizens and the sustainability of the healthcare systems.
Access ESMO’s first-of-its-kind international data on the availability of anti-cancer medicines and opioids, and visit the biosimilars information portal.
Learn about the availability of biomolecular technologies to patients, the status of their use and prescription, as well as the potential economic issues in terms of cost and reimbursement, and barriers to accessing them.
Find out how ESMO supports protecting data privacy as well as the collection and use of patient data for retrospective clinical research, biobanks, and population-based disease registries.
Discover how ESMO actively facilitates clinical cancer research, including input into the EU Clinical Trials Regulation, the founding of CAREFOR to safeguard clinical academic cancer research, and ESMO’s offering of research fellowships and clinical trials workshops.
Learn how ESMO’s collaboration in the Clinical Academic Cancer Research Forum (CAREFOR), brings together leading European experts to safeguard and improve the organisation, recognition, and funding of academic clinical research in oncology.
Explore a list of funding organisations, useful links to research groups, research and clinical trials databases, and tools for research projects.
Cancer prevention requires public policies and actions to reduce the risk of developing cancer.
Learn about ESMO’s study to improve working conditions and quality control procedures in order to protect healthcare workers from the adverse effects of occupational exposure to anti-cancer medicines.
Follow the ESMO-initiated multi-stakeholder partnerships in Europe and Asia that propose solutions to eliminate hurdles faced by rare cancer patients, researchers, medical professionals and the pharmaceutical industry working in this field.
With over 24% of ESMO members practicing in Asia-Pacific, ESMO has launched policy activities such as Rare Cancers Asia and will address public policy challenges in the region with data collection, position papers, and educational activities.
Expand your knowledge of global policy issues and ESMO’s collaboration with the World Health Organization to implement the 2017 WHO Cancer Resolution and support countries to achieve the 2030 United Nations goal of Universal Health Coverage.
Learn about ESMO’s position on a wide range of legislative and non-legislative policy files on both EU and global levels. Discover ESMO’s contributions that shape policy and legislation for the oncology community.
The ESMO National Societies Committee focuses on public policy, ESMO initiatives, and in reinforcing the specialisation of Medical Oncology.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.